Companies › Suzhou Alphamab
3 active drug programs in 7 registered trials: 3 Phase 1, 3 Phase 3, 1 Phase 2; Cardiovascular, Genitourinary, Other, Hematology; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| KN057 Tissue factor pathway inhibitor (TFPI) analog | – | Phase 3 | Hemophilia A With Inhibitor; Hemophilia A Without Inhibitor; Hemophilia A or B | Dec 2026 |
| KN060 Factor XI inhibitor | F11 | Phase 2 | Knee Arthroplasty, Total; Hypertension; End-Stage Renal Disease Requiring Haemodialysis | Dec 2026 |
| KN069 | – | Phase 1 | Overweight or Obesity | Apr 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT06312475 | KN057 | Phase 3 | Hemophilia A With Inhibitor | Hematology | Oct 2025 |
| NCT06180889 | KN060 | Phase 2 | Knee Arthroplasty, Total | Other | Dec 2025 |
| NCT06569108 | KN057 | Phase 3 | Hemophilia A Without Inhibitor | Hematology | Dec 2026 |
| NCT07191899 | KN060 | Phase 1 | Hypertension | Cardiovascular | Dec 2026 |
| NCT06547775 | KN069 | Phase 1 | Overweight or Obesity | Metabolic and endocrine | Apr 2027 |
| NCT07201467 | KN060 | Phase 1 | End-Stage Renal Disease Requiring Haemodialysis | Genitourinary | Aug 2027 |
| NCT07545395 | KN057 | Phase 3 | Hemophilia A or B | Hematology | Dec 2027 |
Regeneron Pharmaceuticals Anthos Therapeutics Johnson & Johnson (Janssen) Sirnaomics
Shenzhen Salubris Pharmaceuticals JW Pharmaceutical Beijing QL Biopharmaceutical ScinnoHub Pharmaceutical Shanghai Minwei Biotechnology
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.